insights_auto
Outlook: 64.7% bullish·11.8% bearish
Go to analysischevron_right
ARGX:NASDAQ
argenx SE - ADR
928,44 USD
0,00%
(0,00) 1D
810,15 USD
arrow_downward
-12,74% (-118,29)todayPre-market
Closed: 7-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Mkt. cap
58,78 млд
Avg. vol.
263,56 миң
Volume
97,76 миң
P/E ratio
35,27
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 миң
Mkt. cap
58,78 млд
Avg. vol.
263,56 миң
Volume
97,76 миң
P/E ratio
35,27
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
GuruFocus
·
39 мүнөт мурун
argenx (ARGX) Shares Drop 14.2% Pre-Market Amid Market Uncertain
TradingView
·
47 мүнөт мурун
Why Is ARGX Stock Plunging Today?
Benzinga
·
52 мүнөт мурун
Argenx Halts Phase 3 Study in Rare Disease Following Futility Analysis
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR